Estudo randomizado embasa o uso de heparina em dose terapêutica para pacientes não críticos internados por Covid-19.
18 Out, 2021 | 08:57hEstudos relacionados (alguns resultados conflitantes)
Comentário no Twitter
What are the effects of therapeutic heparin compared with prophylactic heparin among moderately ill patients with covid-19 admitted to hospital? #BMJResearch by @sholzberg and colleagues.
Includes a #VisualAbstract summarising the study #BMJInfographichttps://t.co/82VisuBKSU pic.twitter.com/b06TdIJvLX
— The BMJ (@bmj_latest) October 15, 2021